Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Uncontrolled Hypertension: early-phase trial registry
6 of 11 indexed Uncontrolled Hypertension trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 6 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Uncontrolled Hypertension: 11 US clinical trials tracked, 6 recruiting.
Uncontrolled Hypertension is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Wake Forest University Health Sciences, running 2 of these trials.
Enrollment posture brief
Registry condition uncontrolled-hypertension
OPEN 6 | RECR 55% | LATE 1 | EARLY 2 | RANK #1577 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Advanced Ovarian Carcinoma (55% recruiting · 11 trials)
Uncontrolled Hypertension lists 6 open slots (55% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Uncontrolled Hypertension on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Uncontrolled Hypertension is recruiting above its size-band peers.
6 of 11 indexed trials (54.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Uncontrolled Hypertension research.
Wake Forest University Health Sciences accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical Uncontrolled Hypertension enrolment sits around 240 participants.
Median target enrolment is 240 among the 11 trials that report a genuine target (sentinel values excluded). 3 of those (27.3%) plan for fewer than 100 participants.
-
Uncontrolled Hypertension research is mostly interventional.
11 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Remote Hypertension Management for Black Patients
Wake Forest University Health Sciences
NCT06527794
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Retension Pharmaceuticals.
NCT07142356
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
Vanda Pharmaceuticals
NCT07090161
Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity
Wake Forest University Health Sciences
NCT07031739
Wearable Evaluation of Ambulatory Readings for Blood Pressure
Stephen Juraschek
NCT06610448
Renal Pelvic Denervation Pilot Trial
Verve Medical
NCT07005050
Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes.
Morehouse School of Medicine
NCT06926855
Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project)
Johns Hopkins University
NCT02674464
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
AstraZeneca
NCT06034743
Technology Coaching Intervention for Black Women With Hypertension
University of North Carolina, Charlotte
NCT03577990
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Vivek Reddy
NCT01635998
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Uncontrolled Hypertension records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Uncontrolled Hypertension trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Uncontrolled Hypertension page
11 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Uncontrolled Hypertension trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Wake Forest University Health Sciences sponsors the most Uncontrolled Hypertension trials on record, review their full trial history before evaluating a specific study. See Wake Forest University Health Sciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Uncontrolled Hypertension condition card totals 11 registered trials; most-linked intervention Placebo; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.